VentiRx Pharmaceuticals' Series A - II Round

VentiRx Pharmaceuticals raised a round of funding on January 15, 2010.

VentiRx Pharmaceuticals is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies for the treatment of cance…

Articles about VentiRx Pharmaceuticals' Series A - II Round: